Cannabis Use Disorder
98
33
36
40
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
22 trials with published results (22%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.1%
4 terminated out of 98 trials
90.9%
+4.4% vs benchmark
7%
7 trials in Phase 3/4
55%
22 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (98)
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
Pregnenolone for Cannabis Use Disorder and Depression
Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)
Study of an Oral Fluid Testing Approach
The Neural Underpinnings of Depression and Cannabis Use in Young People Living With HIV
Neuroimaging of Adolescent Cannabis Use Treatment
Longitudinal Outpatient Treatment for Cannabis Use Disorder
Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder
Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use
Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use
Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
Sex Differences in Neurobehavioral Response to THC
A Study of Cannabidiol in Young Adult Cannabis Users
Cannabidiol and Cannabis Concentrate Users
Stress and Pain in People Living With HIV
Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study
RS-tDCS for Cannabis Use Disorder: The C.A.R.E.S. Initiative
A Brief Intervention for Cannabis Use
Deep Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder